Home > Income Statement > NATH BIOGENES (INDIA)
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2013Mar2012
Consolidated Net Profit ₹1,174,569 Cr₹920,064 Cr₹9.20 Cr₹9.20 Cr

What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?

The latest Consolidated Net Profit ratio of NATH BIOGENES (INDIA) is ₹1,174,569 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹1,174,569 Cr
Mar2022₹920,064 Cr
Mar2013₹9.20 Cr
Mar2012₹9.20 Cr

How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹1,174,569 Cr
27.66
Mar2022 ₹920,064 Cr
9,999,504.72
Mar2013 ₹9.20 Cr
0.00
Mar2012 ₹9.20 Cr -

Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹388.4 Cr 2.4% 17.6% 27% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,877.8 Cr -1.3% -0.5% 49.7% Stock Analytics
KAVERI SEED COMPANY ₹4,366.9 Cr 0.8% 36.2% 62.5% Stock Analytics
VENKYS (INDIA) ₹2,561.7 Cr 2% 18.2% 15.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹2,288.2 Cr -1% -2% -39.2% Stock Analytics
TIERRA AGROTECH ₹485.9 Cr 8.1% 10.2% -39.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

2.4%

17.6%

27%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses